Using digital phenotyping to index 12-month treatment effects of xanomeline and trospium chloride on physical activity in outpatients with schizophrenia

Journal article

Peer reviewed

P.D. Harvey, S.A. Chaturvedi, W.P. Horan, A. Claxton, C. Sauder, T.R. Patel and I. Kaul

Neuroscience Applied, Vol.5, p.106839

2026

Files and links (1)

url

https://doi.org/10.1016/j.nsa.2025.106839View

Published (Version of record) Open

1 Record Views

Title: Using digital phenotyping to index 12-month treatment effects of xanomeline and trospium chloride on physical activity in outpatients with schizophrenia
Creators: P.D. Harvey - University Of Miami Miller School of Medicine, Division of Psychology, Miami, United States
S.A. Chaturvedi - Bristol Myers Squibb, Medical Affairs, Princeton, United States
W.P. Horan - Bristol-Myers Squibb (United States)
A. Claxton - Bristol Myers Squibb, Medical Affairs, Princeton, United States
C. Sauder - Bristol Myers Squibb, Medical Affairs, Princeton, United States
T.R. Patel - Bristol Myers Squibb, Medical Affairs, Princeton, United States
I. Kaul - Bristol Myers Squibb, Medical Affairs, Princeton, United States
Publication Details: Neuroscience Applied, Vol.5, p.106839
Publisher: Elsevier B.V
Academic Unit: Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
Language: English
Resource Type: Journal article
Record Identifier: 991032939567102976